Recombinant erythropoietin is widely used as a therapeutic treatment for anemia. It is typically produced in mammalian cells, such as Chinese Hamster Ovary (CHO) cells, to ensure proper glycosylation, which is essential for its therapeutic efficacy. Upon administration to the patient, erythropoietin binds to the erythropoietin receptor (EPOR) on target cells, stimulating the differentiation and proliferation of hematopoietic stem cells into mature red blood cells.

Virus-like Particles (VLPs) are formed by the self-assembly of viral capsid proteins produced through recombinant DNA technology. High-purity proteins are essential for VLP-based vaccines, achieved through advanced purification techniques such as chromatography and filtration. Once purified, VLPs are combined with adjuvants to enhance immunogenicity, offering an effective platform for vaccine development.

Enzymes serve a wide range of industrial applications, including waste treatment and biofuel production. They are typically produced in microorganisms through large-scale fermentation processes. Following fermentation, the enzymes are extracted, purified, and lyophilized, resulting in a stable powdered form suitable for commercial use.

Membrane proteins, categorized as integral or peripheral, are embedded within or associated with the lipid bilayer, performing essential roles in cellular processes. Studying these proteins requires their isolation and purification using advanced techniques, enabling researchers to unravel their structure, function, and the implications of their dysfunction.

The method of protein harvesting depends on whether the protein is produced intracellularly or secreted into the culture medium. Intracellular proteins require cell lysis techniques, such as sonication, bead milling, or freeze-thaw cycles, followed by clarification to remove cellular debris. In contrast, secreted proteins are typically recovered through centrifugation and/or filtration to separate the cells from the supernatant efficiently.

Chromatography is the primary method for purifying recombinant proteins. However, the diverse nature and properties of proteins, combined with the need for scalability and operational efficiency, necessitate including alternative methods such as precipitation, crystallization, or phase separation during purification process development.

Unlike antibodies, which benefit from well-established and extensively characterized platform chromatography processes, the purification of other recombinant proteins often lacks such standardized approaches. As a result, developing purification processes for recombinant proteins requires more extensive selection, optimization and method development to achieve the desired purity and yield.